Company · CIK 0001476963 · SIC 2834 — Pharmaceutical Preparations
HEAT BIOLOGICS, INC. · HTBX
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 1, 2019 AForm 4 → | Jan 3, 4:50 pm EST | Jeff Tobin HutchinsChief Scientific Officer | 143,140 | — | — | 143,140 | — | plan? |
| Jan 1, 2019 AForm 4 → | Jan 3, 4:50 pm EST | John K A PrendergastDirector | 300,000 | — | — | 300,000 | — | plan? |
| Jan 1, 2019 AForm 4 → | Jan 3, 4:50 pm EST | Jeffrey Alan WolfChief Executive Officer, Director | 800,000 | — | — | 848,317 | — | plan? |
| Jan 1, 2019 AForm 4 → | Jan 3, 4:50 pm EST | Ann A RosarVP of Finance | 89,430 | — | — | 93,379 | — | plan? |
| Jan 8, 2018 AForm 4 → | Jan 10, 6:01 am EST | Ann A RosarVP of Finance | 45,000 | — | — | 108,236 | — | plan? |
| Jan 8, 2018 AForm 4 → | Jan 10, 6:01 am EST | Jeffrey Alan WolfChief Executive Officer, Director | 665,720 | — | — | 886,950 | — | plan? |
| Apr 28, 2017 AForm 4 → | May 2, 12:23 pm EDT | Jeffrey Alan WolfChief Executive Officer, Director | 271,752 | — | — | 716,195 | — | plan? |
| Apr 28, 2017 AForm 4 → | May 2, 12:22 pm EDT | Edward B Smith IIIDirector | 345,753 | — | — | 1,033,046 | — | plan? |
| Apr 28, 2017 AForm 4 → | May 2, 12:21 pm EDT | John J MonahanDirector | 3,958 | — | — | 5,169 | — | plan? |
| Feb 7, 2017 FForm 4 → | Feb 9, 4:30 pm EST | Ann A RosarVP of Finance | 6,764 | $0.8776 | $5,936 | 63,236 | — | plan? |
| Jan 2, 2017 AForm 4 → | Jan 4, 4:32 pm EST | Ann A RosarVP of Finance | 70,000 | — | — | 70,000 | — | plan? |
| Dec 30, 2016 AForm 4 → | Jan 4, 2017, 4:33 pm EST | Jeffrey Alan WolfChief Executive Officer, Director | 200,000 | — | — | 204,881 | — | plan? |
| Mar 23, 2016 PForm 4 → | Mar 23, 8:12 pm EDT | Michael KharitonovDirector | 900,000 | $0.75 | $675,000 | 949,960 | +1,801% | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 1, 2019 AForm 4 → | Jan 3, 4:50 pm EST | Jeff Tobin HutchinsChief Scientific Officer | 356,860 | — | — | 356,860 | — | |
| Jan 1, 2019 AForm 4 → | Jan 3, 4:50 pm EST | Edward B Smith IIIDirector | 150,000 | — | — | 150,000 | — | |
| Jan 1, 2019 AForm 4 → | Jan 3, 4:50 pm EST | Jeffrey Alan WolfChief Executive Officer, Director | 800,000 | — | — | 800,000 | — | |
| Jan 1, 2019 AForm 4 → | Jan 3, 4:50 pm EST | John J MonahanDirector | 150,000 | — | — | 150,000 | — | |
| Jan 1, 2019 AForm 4 → | Jan 3, 4:50 pm EST | Ann A RosarVP of Finance | 110,570 | — | — | 110,570 | — | |
| Jan 8, 2018 AForm 4 → | Jan 10, 6:01 am EST | Edward B Smith IIIDirector | 95,294 | — | — | 95,294 | — | |
| Jan 8, 2018 AForm 4 → | Jan 10, 6:01 am EST | Jeff Tobin HutchinsChief Scientific Officer | 296,471 | — | — | 296,471 | — | |
| Jan 8, 2018 AForm 4 → | Jan 10, 6:01 am EST | John K A PrendergastDirector | 190,588 | — | — | 190,588 | — | |
| Jan 8, 2018 AForm 4 → | Jan 10, 6:01 am EST | Ann A RosarVP of Finance | 66,176 | — | — | 66,176 | — | |
| Jan 8, 2018 AForm 4 → | Jan 10, 6:01 am EST | Jeffrey Alan WolfChief Executive Officer, Director | 595,588 | — | — | 595,588 | — | |
| Jan 8, 2018 AForm 4 → | Jan 10, 6:01 am EST | John J MonahanDirector | 95,294 | — | — | 95,294 | — | |
| Jun 29, 2017 AForm 4 → | Jun 30, 12:41 pm EDT | Ann A RosarVP of Finance | 25,000 | — | — | 25,000 | — | |
| Jun 29, 2017 AForm 4 → | Jun 30, 12:40 pm EDT | Jeff Tobin HutchinsCSO/COO | 100,000 | — | — | 100,000 | — | |
| Jan 2, 2017 AForm 4 → | Jan 9, 2:27 pm EST | Jeff Tobin HutchinsChief Scientific Officer | 200,000 | — | — | 200,000 | — | late |
| Jan 2, 2017 AForm 4 → | Jan 4, 4:34 pm EST | Edward B Smith IIIDirector | 90,000 | — | — | 90,000 | — | |
| Jan 2, 2017 AForm 4 → | Jan 4, 4:33 pm EST | John K A PrendergastDirector | 180,000 | — | — | 180,000 | — | |
| Jan 2, 2017 AForm 4 → | Jan 4, 4:32 pm EST | Ann A RosarVP of Finance | 70,000 | — | — | 70,000 | — | |
| Jan 2, 2017 AForm 4 → | Jan 4, 4:31 pm EST | John J MonahanDirector | 90,000 | — | — | 90,000 | — | |
| Dec 30, 2016 AForm 4 → | Jan 4, 2017, 4:33 pm EST | Jeffrey Alan WolfChief Executive Officer, Director | 200,000 | — | — | 125,000 | — | |
| Apr 21, 2016 AForm 4 → | Apr 25, 7:59 am EDT | John K A PrendergastDirector | 40,000 | — | — | 40,000 | — | |
| Apr 5, 2016 AForm 4 → | Apr 7, 9:47 am EDT | Ann A RosarVP of Finance and Controller | 20,000 | — | — | 20,000 | — | |
| Mar 23, 2016 AForm 4 → | Mar 23, 8:12 pm EDT | Michael KharitonovDirector | 675,000 | $0.75 | $506,250 | 675,000 | — | |
| Jan 11, 2016 AForm 4 → | Jan 13, 5:20 pm EST | Taylor SchreiberChief Scientific Officer | 57,567 | — | — | 57,567 | — | |
| Jan 11, 2016 AForm 4 → | Jan 13, 5:20 pm EST | Anil K. GoyalVP of Business Development | 21,587 | — | — | 21,587 | — | |
| Jan 11, 2016 AForm 4 → | Jan 13, 5:20 pm EST | Edward B Smith IIIDirector, 10% Owner | 23,810 | — | — | 23,810 | — | |
| Jan 11, 2016 AForm 4 → | Jan 13, 5:20 pm EST | Jeffrey Alan WolfChief Executive Officer, Director, 10% Owner | 94,048 | — | — | 94,048 | — | |
| Jan 11, 2016 AForm 4 → | Jan 13, 5:20 pm EST | Michael KharitonovDirector | 23,810 | — | — | 23,810 | — | |
| Jan 11, 2016 AForm 4 → | Jan 13, 5:20 pm EST | Paul BelskyDirector | 23,810 | — | — | 23,810 | — | |
| Jan 11, 2016 AForm 4 → | Jan 13, 5:20 pm EST | Melissa PriceVP of Product Development | 51,587 | — | — | 51,587 | — | |
| Jan 11, 2016 AForm 4 → | Jan 13, 5:20 pm EST | Louis C BockDirector | 23,810 | — | — | 23,810 | — | |
| Jan 11, 2016 AForm 4 → | Jan 13, 5:20 pm EST | John J MonahanDirector | 23,810 | — | — | 23,810 | — | |
| Nov 30, 2015 AForm 4 → | Dec 1, 9:37 am EST | Timothy J CreechChief Financial Officer | 70,000 | — | — | — | — | |
| Jul 23, 2015 AForm 4 → | Jul 27, 9:45 am EDT | Taylor SchreiberChief Scientific Officer | 35,000 | — | — | 35,000 | — | |
| Jan 12, 2015 AForm 4 → | Jan 14, 5:20 pm EST | Jeffrey Alan WolfChief Executive Officer, Director, 10% Owner | 12,500 | — | — | 12,500 | — | |
| Jan 12, 2015 AForm 4 → | Jan 14, 5:19 pm EST | Taylor SchreiberVice President of Research | 10,000 | — | — | 10,000 | — | |
| Jan 12, 2015 AForm 4 → | Jan 14, 5:18 pm EST | Anil K. GoyalVP of Business Development | 12,500 | — | — | 12,500 | — | |
| Oct 15, 2014 AForm 4 → | Feb 27, 2015, 1:09 pm EST | Melissa PriceVP Clinical/Regulatory Affairs | 10,000 | — | — | 10,000 | — | late |